Clinical Trials Browser

Recurrence × fludarabine × CNS × Clear all

NCT01822652 2025-02-24

GRAIN

Phase 1 Active not recruiting

Neuroblastoma, Recurrence

NCT02761915 2021-08-17

A Phase I Trial of Anti-GD2 T-cells (1RG-CART)

Phase 1 Completed

17 enrolled 17 charts

Cytokine Release Syndrome, Neuroblastoma, Recurrence